FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387053721> ?p ?o ?g. }

• W4387053721 endingPage "6182" @default.
• W4387053721 startingPage "6182" @default.
• W4387053721 abstract "The use of oral anticoagulants (OACs) in patients with atrial fibrillation (AF) and low stroke risk might cause more harm than benefit. Little attention has been given to address its prevalence and associated consequences. This study aimed to investigate the prescription rate of OACs, identify associated factors, and describe incident bleeding events in low-risk patients.We included patients with a new diagnosis of AF between 1 January 2011 and 31 December 2018 having a low risk of stroke (CHA2DS2-VASc score of 0 for males and 1 for females) from Australian general practice data (MedicineInsight). Patients were classified as OAC users if there was a recorded prescription of an OAC within 60 days of AF diagnosis, and factors associated with the prescription of an OAC were assessed using logistic regression. Recorded incident bleeding events were identified within 6 months after AF diagnosis or after OAC initiation for OAC non-users and users, respectively. The risk of bleeding was compared between the two groups by adjusting their baseline differences using propensity score matching.The study included 2810 low-risk patients (62.3% male) with a mean age of 49.3 ± 10.8 years. Of the total, 705 (25.1%) patients had a record of OAC prescription within 60 days of diagnosis of AF. Older age (odds ratio [OR] 1.03; 95% confidence interval [CI] 1.03-1.04) and diagnosis periods (2015-2016 [OR 1.46; 95% CI 1.10-1.94] and 2017-2018 [OR 1.65; 95% CI 1.17-2.23] vs. 2011-2012) were associated with higher odds of OAC initiation. Female sex (OR 0.71; 95% CI 0.59-0.85), higher bleeding risk (ORBIT score; OR 0.80; 95% CI 0.68-0.94), and higher socioeconomic index for areas (SEIFA) quintiles (SEIFA quintiles; 2 [OR 0.65; 95% CI 0.48-0.88], 3 [OR 0.74; 95% CI 0.56-0.98], 4 [OR 0.70; 95% CI 0.52-0.94], 5 [OR 0.69; 95% CI 0.52-0.91] compared with quintile 1) were associated with lower odds of OAC prescription. A total of 52 (in 1.8% of patients) incident bleeds were identified, with 18 (2.6%) among OAC users. The rate of bleeding was not significantly different between users and non-users after matching. However, within OAC users, commencement of OAC was associated with an increased risk of bleeding compared to the period before OAC initiation (p = 0.006).One in four patients at low risk of stroke received an OAC within 60 days of AF diagnosis. Older age and the period following the widespread availability of direct-acting OACs were associated with an increased likelihood of OAC prescription. Positively, using OACs was not associated with an increased rate of bleeding compared to non-users." @default.
• W4387053721 created "2023-09-27" @default.
• W4387053721 creator A5006038504 @default.
• W4387053721 creator A5025282229 @default.
• W4387053721 creator A5074193099 @default.
• W4387053721 date "2023-09-25" @default.
• W4387053721 modified "2023-10-17" @default.
• W4387053721 title "Oral Anticoagulant Use in Patients with Atrial Fibrillation at Low Risk of Stroke and Associated Bleeding Complications" @default.
• W4387053721 cites W1984364985 @default.
• W4387053721 cites W1999468381 @default.
• W4387053721 cites W2002012774 @default.
• W4387053721 cites W2036193982 @default.
• W4387053721 cites W2121394112 @default.
• W4387053721 cites W2152623033 @default.
• W4387053721 cites W2162586165 @default.
• W4387053721 cites W2195719407 @default.
• W4387053721 cites W2298220628 @default.
• W4387053721 cites W2338123562 @default.
• W4387053721 cites W2518330835 @default.
• W4387053721 cites W2783817206 @default.
• W4387053721 cites W2897698963 @default.
• W4387053721 cites W2945933197 @default.
• W4387053721 cites W2959873153 @default.
• W4387053721 cites W3005230727 @default.
• W4387053721 cites W3005342950 @default.
• W4387053721 cites W3082188176 @default.
• W4387053721 cites W3107490699 @default.
• W4387053721 cites W3107986792 @default.
• W4387053721 cites W3115280625 @default.
• W4387053721 cites W3138917052 @default.
• W4387053721 cites W3166542644 @default.
• W4387053721 cites W3178314903 @default.
• W4387053721 cites W4200153018 @default.
• W4387053721 cites W4205113539 @default.
• W4387053721 cites W4214617114 @default.
• W4387053721 cites W4220698511 @default.
• W4387053721 cites W4284978005 @default.
• W4387053721 cites W4294236164 @default.
• W4387053721 cites W4296362370 @default.
• W4387053721 cites W4310044165 @default.
• W4387053721 cites W4323268851 @default.
• W4387053721 cites W4361291466 @default.
• W4387053721 cites W4366983660 @default.
• W4387053721 cites W4377294361 @default.
• W4387053721 doi "https://doi.org/10.3390/jcm12196182" @default.
• W4387053721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37834830" @default.
• W4387053721 hasPublicationYear "2023" @default.
• W4387053721 type Work @default.
• W4387053721 citedByCount "0" @default.
• W4387053721 crossrefType "journal-article" @default.
• W4387053721 hasAuthorship W4387053721A5006038504 @default.
• W4387053721 hasAuthorship W4387053721A5025282229 @default.
• W4387053721 hasAuthorship W4387053721A5074193099 @default.
• W4387053721 hasBestOaLocation W43870537211 @default.
• W4387053721 hasConcept C126322002 @default.
• W4387053721 hasConcept C127413603 @default.
• W4387053721 hasConcept C142454548 @default.
• W4387053721 hasConcept C151956035 @default.
• W4387053721 hasConcept C156957248 @default.
• W4387053721 hasConcept C17923572 @default.
• W4387053721 hasConcept C2426938 @default.
• W4387053721 hasConcept C2779161974 @default.
• W4387053721 hasConcept C2780645631 @default.
• W4387053721 hasConcept C44249647 @default.
• W4387053721 hasConcept C67774102 @default.
• W4387053721 hasConcept C71924100 @default.
• W4387053721 hasConcept C78519656 @default.
• W4387053721 hasConcept C82789193 @default.
• W4387053721 hasConcept C98274493 @default.
• W4387053721 hasConceptScore W4387053721C126322002 @default.
• W4387053721 hasConceptScore W4387053721C127413603 @default.
• W4387053721 hasConceptScore W4387053721C142454548 @default.
• W4387053721 hasConceptScore W4387053721C151956035 @default.
• W4387053721 hasConceptScore W4387053721C156957248 @default.
• W4387053721 hasConceptScore W4387053721C17923572 @default.
• W4387053721 hasConceptScore W4387053721C2426938 @default.
• W4387053721 hasConceptScore W4387053721C2779161974 @default.
• W4387053721 hasConceptScore W4387053721C2780645631 @default.
• W4387053721 hasConceptScore W4387053721C44249647 @default.
• W4387053721 hasConceptScore W4387053721C67774102 @default.
• W4387053721 hasConceptScore W4387053721C71924100 @default.
• W4387053721 hasConceptScore W4387053721C78519656 @default.
• W4387053721 hasConceptScore W4387053721C82789193 @default.
• W4387053721 hasConceptScore W4387053721C98274493 @default.
• W4387053721 hasIssue "19" @default.
• W4387053721 hasLocation W43870537211 @default.
• W4387053721 hasLocation W43870537212 @default.
• W4387053721 hasOpenAccess W4387053721 @default.
• W4387053721 hasPrimaryLocation W43870537211 @default.
• W4387053721 hasRelatedWork W1997300706 @default.
• W4387053721 hasRelatedWork W2026576563 @default.
• W4387053721 hasRelatedWork W2036193982 @default.
• W4387053721 hasRelatedWork W2065417422 @default.
• W4387053721 hasRelatedWork W213628847 @default.
• W4387053721 hasRelatedWork W2275925001 @default.
• W4387053721 hasRelatedWork W3018339811 @default.
• W4387053721 hasRelatedWork W3023923059 @default.
• W4387053721 hasRelatedWork W3196761963 @default.

• next